{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:10:37Z","timestamp":1783937437909,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T00:00:00Z","timestamp":1486512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T00:00:00Z","timestamp":1486512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Moyamoya disease (MMD) is an idiopathic disease associated with recurrent stroke. However, the pathogenesis of MMD remains unknown. Therefore, we performed long noncoding RNA (lncRNA) and messenger RNA (mRNA) expression profiles in blood samples from MMD patients (N\u2009=\u200915) and healthy controls (N\u2009=\u200910). A total of 880 differentially expressed lncRNAs (3649 probes) and 2624 differentially expressed mRNAs (2880 probes) were obtained from the microarrays of MMD patients and healthy controls (P\u2009&lt;\u20090.05; Fold Change &gt;2.0). Gene ontology (GO) and pathway analyses showed that upregulated mRNAs were enriched for inflammatory response, Toll-like receptor signaling pathway, chemokine signaling pathway and mitogen-activated protein kinase (MAPK) signaling pathway among others, while the downregulated mRNAs were enriched for neurological system process, digestion, drug metabolism, retinol metabolism and others. Our results showed that the integrated analysis of lncRNA-mRNA co-expression networks were linked to inflammatory response, Toll-like signaling pathway, cytokine-cytokine receptor interaction and MAPK signaling pathway. These findings may elucidate the pathogenesis of MMD, and the differentially expressed genes could provide clues to find key components in the MMD pathway.<\/jats:p>","DOI":"10.1038\/srep42421","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T10:11:59Z","timestamp":1486548719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Integrated Analysis of LncRNA-mRNA Co-Expression Profiles in Patients with Moyamoya Disease"],"prefix":"10.1038","volume":"7","author":[{"given":"Wen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faliang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,8]]},"reference":[{"key":"BFsrep42421_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki, J. & Takaku, A. Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20, 288\u2013299 (1969).","journal-title":"Arch Neurol"},{"key":"BFsrep42421_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.clineuro.2008.09.022","volume":"111","author":"A Narisawa","year":"2009","unstructured":"Narisawa, A., Fujimura, M. & Tominaga, T. Efficacy of the revascularization surgery for adult-onset moyamoya disease with the progression of cerebrovascular lesions. Clin Neurol Neurosurg 111, 123\u2013126, doi: 10.1016\/j.clineuro.2008.09.022 (2009).","journal-title":"Clin Neurol Neurosurg"},{"key":"BFsrep42421_CR3","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1016\/S0303-8467(97)00082-6","volume":"99","author":"M Fukui","year":"1997","unstructured":"Fukui, M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (\u2018moyamoya\u2019 disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99 Suppl 2, S238\u2013240 (1997).","journal-title":"Clin Neurol Neurosurg"},{"key":"BFsrep42421_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5853\/jos.2014.16.2.65","volume":"16","author":"M Fujimura","year":"2014","unstructured":"Fujimura, M. et al. Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene. J Stroke 16, 65\u201372, doi: 10.5853\/jos.2014.16.2.65 (2014).","journal-title":"J Stroke"},{"key":"BFsrep42421_CR5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/482310a","volume":"482","author":"MS Kowalczyk","year":"2012","unstructured":"Kowalczyk, M. S., Higgs, D. R. & Gingeras, T. R. Molecular biology: RNA discrimination. Nature 482, 310\u2013311, doi: 10.1038\/482310a (2012).","journal-title":"Nature"},{"key":"BFsrep42421_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"TR Mercer","year":"2009","unstructured":"Mercer, T. R., Dinger, M. E. & Mattick, J. S. Long non-coding RNAs: insights into functions. Nat Rev Genet 10, 155\u2013159, doi: 10.1038\/nrg2521 (2009).","journal-title":"Nat Rev Genet"},{"key":"BFsrep42421_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gpb.2015.09.006","volume":"14","author":"Y Fang","year":"2016","unstructured":"Fang, Y. & Fullwood, M. J. Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer. Genomics Proteomics Bioinformatics 14, 42\u201354, doi: 10.1016\/j.gpb.2015.09.006 (2016).","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"BFsrep42421_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.it.2014.07.005","volume":"35","author":"JA Heward","year":"2014","unstructured":"Heward, J. A. & Lindsay, M. A. Long non-coding RNAs in the regulation of the immune response. Trends Immunol 35, 408\u2013419, doi: 10.1016\/j.it.2014.07.005 (2014).","journal-title":"Trends Immunol"},{"key":"BFsrep42421_CR9","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1073\/pnas.1313768111","volume":"111","author":"Z Li","year":"2014","unstructured":"Li, Z. et al. The long noncoding RNA THRIL regulates TNFalpha expression through its interaction with hnRNPL. Proc Natl Acad Sci USA 111, 1002\u20131007, doi: 10.1073\/pnas.1313768111 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep42421_CR10","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0002-9440(10)63450-5","volume":"163","author":"B Stuhlmuller","year":"2003","unstructured":"Stuhlmuller, B. et al. Detection of oncofetal h19 RNA in rheumatoid arthritis synovial tissue. Am J Pathol 163, 901\u2013911, doi: 10.1016\/S0002-9440(10)63450-5 (2003).","journal-title":"Am J Pathol"},{"key":"BFsrep42421_CR11","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/art.38309","volume":"66","author":"Q Liu","year":"2014","unstructured":"Liu, Q. et al. Long noncoding RNA related to cartilage injury promotes chondrocyte extracellular matrix degradation in osteoarthritis. Arthritis Rheumatol 66, 969\u2013978, doi: 10.1002\/art.38309 (2014).","journal-title":"Arthritis Rheumatol"},{"key":"BFsrep42421_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/art.39520","volume":"68","author":"MJ Pearson","year":"2016","unstructured":"Pearson, M. J. et al. Long Intergenic Noncoding RNAs Mediate the Human Chondrocyte Inflammatory Response and Are Differentially Expressed in Osteoarthritis Cartilage. Arthritis Rheumatol 68, 845\u2013856, doi: 10.1002\/art.39520 (2016).","journal-title":"Arthritis Rheumatol"},{"key":"BFsrep42421_CR13","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/febs.13660","volume":"283","author":"S Su","year":"2016","unstructured":"Su, S. et al. Overexpression of the long noncoding RNA TUG1 protects against cold-induced injury of mouse livers by inhibiting apoptosis and inflammation. FEBS J 283, 1261\u20131274, doi: 10.1111\/febs.13660 (2016).","journal-title":"FEBS J"},{"key":"BFsrep42421_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/15476286.2015.1122164","volume":"13","author":"X Zhou","year":"2016","unstructured":"Zhou, X. et al. Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-kappaB pathway. RNA Biol 13, 98\u2013108, doi: 10.1080\/15476286.2015.1122164 (2016).","journal-title":"RNA Biol"},{"key":"BFsrep42421_CR15","doi-asserted-by":"publisher","first-page":"e2123","DOI":"10.1038\/cddis.2015.407","volume":"7","author":"Y Han","year":"2016","unstructured":"Han, Y. et al. Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK\/MAPK signaling. Cell Death Dis 7, e2123, doi: 10.1038\/cddis.2015.407 (2016).","journal-title":"Cell Death Dis"},{"key":"BFsrep42421_CR16","first-page":"11092","volume":"8","author":"H Yang","year":"2015","unstructured":"Yang, H. et al. Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer. Int J Clin Exp Pathol 8, 11092\u201311099 (2015).","journal-title":"Int J Clin Exp Pathol"},{"key":"BFsrep42421_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5853\/jos.2015.01760","volume":"18","author":"OY Bang","year":"2016","unstructured":"Bang, O. Y., Fujimura, M. & Kim, S. K. The Pathophysiology of Moyamoya Disease: An Update. J Stroke 18, 12\u201320, doi: 10.5853\/jos.2015.01760 (2016).","journal-title":"J Stroke"},{"key":"BFsrep42421_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.wneu.2016.05.081","volume":"93","author":"F Gao","year":"2016","unstructured":"Gao, F. et al. Long Noncoding RNAs and Their Regulatory Network: Potential Therapeutic Targets for Adult Moyamoya Disease. World Neurosurgery 93, 111\u2013119, doi: 10.1016\/j.wneu.2016.05.081 (2016).","journal-title":"World Neurosurgery"},{"key":"BFsrep42421_CR19","doi-asserted-by":"publisher","first-page":"21819","DOI":"10.1038\/srep21819","volume":"6","author":"J Xu","year":"2016","unstructured":"Xu, J. et al. Differentially expressed lncRNAs and mRNAs identified by microarray analysis in GBS patients vs healthy controls. Sci Rep 6, 21819, doi: 10.1038\/srep21819 (2016).","journal-title":"Sci Rep"},{"key":"BFsrep42421_CR20","doi-asserted-by":"crossref","unstructured":"Xu, J. et al. Microarray Analysis of lncRNA and mRNA Expression Profiles in Patients with Neuromyelitis Optica. Mol Neurobiol, doi: 10.1007\/s12035-016-9754-0 (2016).","DOI":"10.1007\/s12035-016-9754-0"},{"key":"BFsrep42421_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5853\/jos.2015.01627","volume":"18","author":"JS Kim","year":"2016","unstructured":"Kim, J. S. Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis. J Stroke 18, 2\u201311, doi: 10.5853\/jos.2015.01627 (2016).","journal-title":"J Stroke"},{"key":"BFsrep42421_CR22","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","volume":"7","author":"S Kuroda","year":"2008","unstructured":"Kuroda, S. & Houkin, K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7, 1056\u20131066, doi: 10.1016\/S1474-4422(08)70240-0 (2008).","journal-title":"Lancet Neurol"},{"key":"BFsrep42421_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/STROKEAHA.107.490714","volume":"39","author":"S Kuriyama","year":"2008","unstructured":"Kuriyama, S. et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39, 42\u201347, doi: 10.1161\/STROKEAHA.107.490714 (2008).","journal-title":"Stroke"},{"key":"BFsrep42421_CR24","doi-asserted-by":"crossref","unstructured":"Han, D. H. et al. A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976\u20131994). The Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien) 142, 1263\u20131273; discussion 1273\u20131264 (2000).","DOI":"10.1007\/s007010070024"},{"key":"BFsrep42421_CR25","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/S0303-8467(97)00036-X","volume":"99","author":"CC Hung","year":"1997","unstructured":"Hung, C. C., Tu, Y. K., Su, C. F., Lin, L. S. & Shih, C. J. Epidemiological study of moyamoya disease in Taiwan. Clin Neurol Neurosurg 99 Suppl 2, S23\u201325 (1997).","journal-title":"Clin Neurol Neurosurg"},{"key":"BFsrep42421_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.clineuro.2009.11.009","volume":"112","author":"W Miao","year":"2010","unstructured":"Miao, W. et al. Epidemiological and clinical features of Moyamoya disease in Nanjing, China. Clin Neurol Neurosurg 112, 199\u2013203, doi: 10.1016\/j.clineuro.2009.11.009 (2010).","journal-title":"Clin Neurol Neurosurg"},{"key":"BFsrep42421_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1161\/STROKEAHA.111.621300","volume":"43","author":"L Duan","year":"2012","unstructured":"Duan, L. et al. Moyamoya disease in China: its clinical features and outcomes. Stroke 43, 56\u201360, doi: 10.1161\/STROKEAHA.111.621300 (2012).","journal-title":"Stroke"},{"key":"BFsrep42421_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada, F. et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 56, 34\u201340, doi: 10.1038\/jhg.2010.132 (2011).","journal-title":"J Hum Genet"},{"key":"BFsrep42421_CR29","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1227\/01.NEU.0000215854.66011.4F","volume":"58","author":"HS Kang","year":"2006","unstructured":"Kang, H. S. et al. Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery 58, 1074\u20131080; discussion 1074\u20131080, doi: 10.1227\/01.NEU.0000215854.66011.4F (2006).","journal-title":"Neurosurgery"},{"key":"BFsrep42421_CR30","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1159\/000319893","volume":"30","author":"H Li","year":"2010","unstructured":"Li, H. et al. Association of a functional polymorphism in the MMP-3 gene with Moyamoya Disease in the Chinese Han population. Cerebrovasc Dis 30, 618\u2013625, doi: 10.1159\/000319893 (2010).","journal-title":"Cerebrovasc Dis"},{"key":"BFsrep42421_CR31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ejmg.2012.05.002","volume":"55","author":"C Liu","year":"2012","unstructured":"Liu, C. et al. Analysis of TGFB1 in European and Japanese Moyamoya disease patients. Eur J Med Genet 55, 531\u2013534, doi: 10.1016\/j.ejmg.2012.05.002 (2012).","journal-title":"Eur J Med Genet"},{"key":"BFsrep42421_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12199-009-0116-7","volume":"15","author":"W Liu","year":"2010","unstructured":"Liu, W. et al. A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians. Environ Health Prev Med 15, 94\u2013104, doi: 10.1007\/s12199-009-0116-7 (2010).","journal-title":"Environ Health Prev Med"},{"key":"BFsrep42421_CR33","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00381-011-1504-z","volume":"27","author":"YS Park","year":"2011","unstructured":"Park, Y. S. et al. Age-specific eNOS polymorphisms in moyamoya disease. Childs Nerv Syst 27, 1919\u20131926, doi: 10.1007\/s00381-011-1504-z (2011).","journal-title":"Childs Nerv Syst"},{"key":"BFsrep42421_CR34","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s00701-010-0711-9","volume":"152","author":"C Roder","year":"2010","unstructured":"Roder, C. et al. Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients. Acta Neurochir (Wien) 152, 2153\u20132160, doi: 10.1007\/s00701-010-0711-9 (2010).","journal-title":"Acta Neurochir (Wien)"},{"key":"BFsrep42421_CR35","doi-asserted-by":"publisher","first-page":"13191","DOI":"10.1038\/srep13191","volume":"5","author":"K Ohkubo","year":"2015","unstructured":"Ohkubo, K. et al. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells. Sci Rep 5, 13191, doi: 10.1038\/srep13191 (2015).","journal-title":"Sci Rep"},{"key":"BFsrep42421_CR36","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3171\/jns.1998.89.4.0623","volume":"89","author":"M Hojo","year":"1998","unstructured":"Hojo, M. et al. Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg 89, 623\u2013629, doi: 10.3171\/jns.1998.89.4.0623 (1998).","journal-title":"J Neurosurg"},{"key":"BFsrep42421_CR37","doi-asserted-by":"publisher","first-page":"9179","DOI":"10.1007\/s13277-015-3453-8","volume":"36","author":"C Zhou","year":"2015","unstructured":"Zhou, C. et al. Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1alpha activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer. Tumour Biol 36, 9179\u20139188, doi: 10.1007\/s13277-015-3453-8 (2015).","journal-title":"Tumour Biol"},{"key":"BFsrep42421_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.pharmthera.2006.04.002","volume":"112","author":"C Bizzarri","year":"2006","unstructured":"Bizzarri, C. et al. ELR\u2009+\u2009CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol Ther 112, 139\u2013149, doi: 10.1016\/j.pharmthera.2006.04.002 (2006).","journal-title":"Pharmacol Ther"},{"key":"BFsrep42421_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/bja\/aeu189","volume":"114","author":"B Muller-Edenborn","year":"2015","unstructured":"Muller-Edenborn, B. et al. Volatile anaesthetics reduce neutrophil inflammatory response by interfering with CXC receptor-2 signalling. Br J Anaesth 114, 143\u2013149, doi: 10.1093\/bja\/aeu189 (2015).","journal-title":"Br J Anaesth"},{"key":"BFsrep42421_CR40","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1016\/j.febslet.2015.08.046","volume":"589","author":"Y Tang","year":"2015","unstructured":"Tang, Y. et al. The lncRNA MALAT1 protects the endothelium against ox-LDL-induced dysfunction via upregulating the expression of the miR-22-3p target genes CXCR2 and AKT. FEBS Lett 589, 3189\u20133196, doi: 10.1016\/j.febslet.2015.08.046 (2015).","journal-title":"FEBS Lett"},{"key":"BFsrep42421_CR41","doi-asserted-by":"publisher","first-page":"e102382","DOI":"10.1371\/journal.pone.0102382","volume":"9","author":"D Dai","year":"2014","unstructured":"Dai, D. et al. Serum miRNA signature in Moyamoya disease. PLoS One 9, e102382, doi: 10.1371\/journal.pone.0102382 (2014).","journal-title":"PLoS One"},{"key":"BFsrep42421_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P. P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146, 353\u2013358, doi: 10.1016\/j.cell.2011.07.014 (2011).","journal-title":"Cell"},{"key":"BFsrep42421_CR43","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1440-1789.2004.00550.x","volume":"24","author":"Y Takekawa","year":"2004","unstructured":"Takekawa, Y., Umezawa, T., Ueno, Y., Sawada, T. & Kobayashi, M. Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease. Neuropathology 24, 236\u2013242 (2004).","journal-title":"Neuropathology"},{"key":"BFsrep42421_CR44","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.3171\/2011.3.FOCUS1151","volume":"30","author":"DG Weinberg","year":"2011","unstructured":"Weinberg, D. G. et al. Moyamoya disease: a review of histopathology, biochemistry, and genetics. Neurosurg Focus 30, E20, doi: 10.3171\/2011.3.FOCUS1151 (2011).","journal-title":"Neurosurg Focus"},{"key":"BFsrep42421_CR45","doi-asserted-by":"publisher","first-page":"11870","DOI":"10.1074\/jbc.M007518200","volume":"276","author":"KM Park","year":"2001","unstructured":"Park, K. M., Chen, A. & Bonventre, J. V. Prevention of kidney ischemia\/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 276, 11870\u201311876, doi: 10.1074\/jbc.M007518200 (2001).","journal-title":"J Biol Chem"},{"key":"BFsrep42421_CR46","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1161\/01.CIR.0000147610.41984.E8","volume":"110","author":"J Nordmeyer","year":"2004","unstructured":"Nordmeyer, J. et al. Upregulation of myocardial estrogen receptors in human aortic stenosis. Circulation 110, 3270\u20133275, doi: 10.1161\/01.CIR.0000147610.41984.E8 (2004).","journal-title":"Circulation"},{"key":"BFsrep42421_CR47","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s10753-015-0242-x","volume":"39","author":"Y Hu","year":"2016","unstructured":"Hu, Y. et al. Icariin Attenuates High-cholesterol Diet Induced Atherosclerosis in Rats by Inhibition of Inflammatory Response and p38 MAPK Signaling Pathway. Inflammation 39, 228\u2013236, doi: 10.1007\/s10753-015-0242-x (2016).","journal-title":"Inflammation"},{"key":"BFsrep42421_CR48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tiv.2016.03.010","volume":"34","author":"KR Paudel","year":"2016","unstructured":"Paudel, K. R., Karki, R. & Kim, D. W. Cepharanthine inhibits in vitro VSMC proliferation and migration and vascular inflammatory responses mediated by RAW264.7. Toxicol In Vitro 34, 16\u201325, doi: 10.1016\/j.tiv.2016.03.010 (2016).","journal-title":"Toxicol In Vitro"},{"key":"BFsrep42421_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11010-014-2068-5","volume":"393","author":"Y Cui","year":"2014","unstructured":"Cui, Y. et al. Platelet-derived growth factor-BB induces matrix metalloproteinase-2 expression and rat vascular smooth muscle cell migration via ROCK and ERK\/p38 MAPK pathways. Mol Cell Biochem 393, 255\u2013263, doi: 10.1007\/s11010-014-2068-5 (2014).","journal-title":"Mol Cell Biochem"},{"key":"BFsrep42421_CR50","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jvs.2011.12.038","volume":"56","author":"PA Suwanabol","year":"2012","unstructured":"Suwanabol, P. A. et al. Transforming growth factor-beta increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways. J Vasc Surg 56, 446\u2013454, doi: 10.1016\/j.jvs.2011.12.038 (2012).","journal-title":"J Vasc Surg"},{"key":"BFsrep42421_CR51","doi-asserted-by":"publisher","first-page":"e79657","DOI":"10.1371\/journal.pone.0079657","volume":"8","author":"A Martin-Garrido","year":"2013","unstructured":"Martin-Garrido, A. et al. Transforming growth factor beta inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation. PLoS One 8, e79657, doi: 10.1371\/journal.pone.0079657 (2013).","journal-title":"PLoS One"},{"key":"BFsrep42421_CR52","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1034\/j.1600-0463.2002.100604.x","volume":"110","author":"M Zhao","year":"2002","unstructured":"Zhao, M. et al. Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL. APMIS 110, 458\u2013468 (2002).","journal-title":"APMIS"},{"key":"BFsrep42421_CR53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10815-015-0630-z","volume":"33","author":"X Huang","year":"2016","unstructured":"Huang, X., Hao, C., Bao, H., Wang, M. & Dai, H. Aberrant expression of long noncoding RNAs in cumulus cells isolated from PCOS patients. J Assist Reprod Genet 33, 111\u2013121, doi: 10.1007\/s10815-015-0630-z (2016).","journal-title":"J Assist Reprod Genet"},{"key":"BFsrep42421_CR54","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498\u20132504, doi: 10.1101\/gr.1239303 (2003).","journal-title":"Genome Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep42421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42421","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T01:12:44Z","timestamp":1671844364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep42421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,8]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,9]]}},"alternative-id":["BFsrep42421"],"URL":"https:\/\/doi.org\/10.1038\/srep42421","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,8]]},"assertion":[{"value":"22 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42421"}}